Sartorius Acquires Novasep’s Chromatography Equipment Division
Novasep (Lyon, France) and Sartorius (Göttingen, Germany) have announced the completion of the sale of Novasep’s chromatography equipment division to Sartorius.
Novasep’s chromatography equipment division comprises resin‑based batch and intensified chromatography systems and focuses on low and high pressure for small and large molecules such as monoclonal antibodies, oligonucleotides, peptides, and insulin. The division generated sales of around 40 million euros in 2020, with the majority of the approximately 100 employees working at Novasep’s Pompey site in eastern France and some in the USA, China, and India.
Since 2018, Novasep and Sartorius have been collaborating in the joint development of an optimized membrane-based, low‑pressure chromatography system that processes larger molecules more productively.
“This achievement strengthens our relationship with the Sartorius team and represents a great opportunity for the chromatography equipment business to fully deliver its potential and accelerate its growth under this new ownership,” said Michel Spagnol, President and CEO of Novasep.
Novasep will continue to offer CDMO development and manufacturing services for the pharmaceutical and biopharmaceutical markets, based on chromatography, which remains a core technology.
For more information, please visit: www.novasep.com
New Study Uses MSPE with GC–MS to Analyze PFCAs in Water
January 20th 2025Scientists from the China University of Sciences combined magnetic solid-phase extraction (MSPE) with gas chromatography–mass spectrometry (GC–MS) to analyze perfluoro carboxylic acids (PFCAs) in different water environments.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
A Guide To Finding the Ideal Syringe and Needle
January 20th 2025Hamilton has produced a series of reference guides to assist science professionals in finding the best-suited products and configurations for their applications. The Syringe and Needle Reference Guide provides detailed information on Hamilton Company’s full portfolio of syringes and needles. Everything from cleaning and preventative maintenance to individual part numbers are available for review. It also includes selection charts to help you choose between syringe terminations like cemented needles and luer tips.
Oasis or Sand Dune? Isolation of Psychedelic Compounds
January 20th 2025Magic mushrooms, once taboo, have recently experienced a renaissance. This new awakening is partially due to new findings that indicate the effects of psilocybin, and its dephosphorylated cousin psilocin may produce long lasting results for patients who might be struggling with anxiety, depression, alcohol and drug abuse, and post-traumatic stress disorder. Hamilton Company has developed a methodology for the isolation and identification of 5 common psychedelic compounds used in the potential treatment of disease. The PRP-1 HPLC column resin remains stable in the harsh alkaline conditions ideal for better separations.
